Advertisement
Research Article

Elevation in Inflammatory Serum Biomarkers Predicts Response to Trastuzumab-Containing Therapy

  • Ahmed A. Alkhateeb,

    Affiliation: Department of Neurosurgery, The Pennsylvania State University Hershey Medical Center, Hershey, Pennsylvania, United States of America

    X
  • Kim Leitzel,

    Affiliation: Division of Hematology-Medical Oncology, The Pennsylvania State University Hershey Medical Center, Hershey, Pennsylvania, United States of America

    X
  • Suhail M. Ali,

    Affiliations: Division of Hematology-Medical Oncology, The Pennsylvania State University Hershey Medical Center, Hershey, Pennsylvania, United States of America, Department of Medicine, Lebanon VA Medical Center, Lebanon, Pennsylvania, United States of America

    X
  • Cynthia Campbell-Baird,

    Affiliation: Division of Hematology-Medical Oncology, The Pennsylvania State University Hershey Medical Center, Hershey, Pennsylvania, United States of America

    X
  • Matthew Evans,

    Affiliation: Division of Hematology-Medical Oncology, The Pennsylvania State University Hershey Medical Center, Hershey, Pennsylvania, United States of America

    X
  • Eva-Maria Fuchs,

    Affiliation: Department of Medicine, Medical University of Vienna, Vienna, Austria

    X
  • Wolfgang J. Köstler,

    Affiliation: Department of Medicine, Medical University of Vienna, Vienna, Austria

    X
  • Allan Lipton,

    Affiliation: Division of Hematology-Medical Oncology, The Pennsylvania State University Hershey Medical Center, Hershey, Pennsylvania, United States of America

    X
  • James Connor mail

    jconnor@hmc.psu.edu

    Affiliation: Department of Neurosurgery, The Pennsylvania State University Hershey Medical Center, Hershey, Pennsylvania, United States of America

    X
  • Published: December 26, 2012
  • DOI: 10.1371/journal.pone.0051379

Reader Comments (0)

Post a new comment on this article